IOL Chemicals With Rs 495 Crore Expansion; Will The Stock See A Re-Rating Or It's Priced In?
Join Us
Follow Us
IOLCP is investing Rs 495 crore to expand Ibuprofen capacity by 50 per cent while entering CDMO and specialty chemicals. The expansion, funded entirely through internal accruals, aims to unlock new high-margin growth opportunities.
✨ Key Takeaways
IOL Chemicals and Pharmaceuticals (IOLCP) has initiated a major backward-integrated capacity expansion for its flagship API product, Ibuprofen, at its flagship site in Barnala, Punjab. The new plant will add 6,000 MT per annum, boosting total manufacturing capacity by 50 per cent from 12,000 MTPA to 18,000 MTPA. Running existing facilities at 95 per cent capacity utilization, this extension addresses growing international market demand and cements IOLCP's global leadership position.
Looking for Hidden Value in the Stock Market?
Explore DSIJ’s Mispriced Gems - a research-driven service focused on uncovering undervalued stocks benefiting from strategic shifts, industry tailwinds, and hidden growth catalysts.
Download Service BrochureStrategic Entry into CDMO and Specialty Chemicals
Marking a key strategic extension, IOLCP is diversifying into Contract Development and Manufacturing Organisation (CDMO) services for pharmaceutical formulations. The dedicated Rs 110 crore facility targets long-term supply needs for anchor European clients and has already secured European GMP compliance from Hungary. Additionally, the company is committing Rs 35 crore toward a dedicated specialty chemicals plant under an exclusive long-term tolling contract with a global industry partner.
Financial and Market Outlook
With a cumulative investment outlay of Rs 495 crore funded entirely via internal accruals, the company maintains its conservative leverage profile while setting up high-margin revenue streams. Both the CDMO and specialty chemicals facilities are scheduled to begin commercial production during Q3 FY 2027, followed by the expanded Ibuprofen unit in December 2027.
About the Company
Established in 1986 and headquartered in Ludhiana, Punjab, IOL Chemicals and Pharmaceuticals Limited is a leading active pharmaceutical ingredients (API) and specialty chemical manufacturer. The company serves a global customer base across generic APIs, specialty chemicals, and high-value formulations.
Also Read - Global Electrode Demand Boom: This Stock Could Be a Key Beneficiary; Shares Rally 16% to 52-week high
Disclaimer: The article is for informational purposes only and not investment advice.